Home Page >> Januvia >> Articles >> Lawyer Interviews
Januvia Lawyer Interviews
June 24, 2017. By Brenda Craig.
Philadelphia, PA Final results from two independent clinical trials indicate the amputation risk for users of the Type 2 Diabetes drug Canagliflozin, marketed as Invokana, Invokamet, Invokamet XR, are much greater than previously understood.Read [ FDA Black Box Warning Adds Fuel to Invokana Lawsuits ]
August 23, 2013. By Brenda Craig.
Read [ Proving the Case - Pancreatic Cancer Patients Point Finger at Diabetes Drugs ]
Philadelphia, PA Health regulators in the US, Canada and Europe have shown they are far from ready to curtail sales or change the labels on any of the widely used type 2 diabetes medications that may or may not have a causal link to increased rates of pancreatitis and pancreatic cancer.
April 20, 2013. By Heidi Turner.
Read [ Januvia Attorney: Januvia Lawsuits Moving Ahead ]
Dallas, TX Januvia lawsuits, alleging patients suffered serious Januvia side effects, are moving ahead, with a motion filed for the lawsuits to be consolidated into a multidistrict litigation. Despite the movement in the litigation, Shezad Malik, medical doctor and founder of the Dr. Shezad Malik Law Firm, says it is not too late for patients to join lawsuits. In fact, he anticipates many more lawsuits involving Januvia and pancreatic cancer to be filed.
March 8, 2013. By Heidi Turner.
Read [ Januvia Studies Link Medication to Serious Side Effects ]
Miami, FL A new study examining Januvia has some critics arguing that patients should talk to their doctor about the risk of Januvia side effects. Although no Januvia lawsuits have been filed, Ben Stewart, attorney at Stewart Law Group PLLC, says he expects lawsuits will be filed in the next few months, alleging patients suffered serious side effects - including thyroid and pancreatic cancer- as a result of using Januvia.